Kovoor Philip Abraham, Hwang Jimmy
Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC 20007, USA.
Expert Rev Anticancer Ther. 2009 Jan;9(1):135-42. doi: 10.1586/14737140.9.1.135.
Gastric cancer is the second leading cause of cancer death worldwide. The local surgical treatment of gastric cancer varies geographically. However, there has been a confluence of opinion regarding the optimal therapy of gastric cancer toward multimodality therapy. In the East, many clinicians pursue adjuvant chemotherapy after a D2 resection. However, in the West, clinicians use either perioperative chemotherapy or postoperative chemoradiation. It remains unclear at this time whether either perioperative approach is the optimal approach.
胃癌是全球癌症死亡的第二大主要原因。胃癌的局部手术治疗在地理上存在差异。然而,对于胃癌的最佳治疗方法已趋向于多模式治疗,在这一点上已达成共识。在东方,许多临床医生在进行D2切除术后会进行辅助化疗。然而,在西方,临床医生要么采用围手术期化疗,要么采用术后放化疗。目前尚不清楚这两种围手术期治疗方法哪种是最佳方法。